Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

British Journal of Cancer

Volumn 62, Issue 3, 1990, Pages 405-409

  Colletta, A A ^a   Wakefield, L M ^b   Howell, F V ^a   Van Roozendaal, K E P ^a   Danielpour, D ^b   Ebbs, S R ^a   Spom, M B ^b   Baum, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DEXAMETHASONE; ESTRADIOL; ESTROGEN RECEPTOR; GESTODENE; MEDROXYPROGESTERONE ACETATE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROMEGESTONE; RADIOISOTOPE; TAMOXIFEN; TAMOXIFEN DERIVATIVE; TOREMIFENE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CANCER; CELL CULTURE; FETUS; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BLOTTING, NORTHERN; DEXAMETHASONE; ESTRADIOL; ESTROGEN ANTAGONISTS; FETUS; FIBROBLASTS; HUMAN; IN VITRO; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE 17-ACETATE; NORPREGNENES; PROMEGESTONE; RECEPTORS, ESTROGEN; RNA; STANOLONE; TAMOXIFEN; TOREMIFENE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0025113699     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1990.307     Document Type: Article

References (28)

1. DANIELPOUR, D., DART, L.L., FLANDERS, K.C., ROBERTS, A.B. & SPORN, M.B. (1989). Immunodetection and quantitation of the two forms of transforming growth factor beta secreted by cells in culture. J. Cell Physiol., 138, 79
2. EARLY BREAST CANCER TRIALLISTS COLLABORATIVE GROUP. (1988). Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: An overview of 61 randomised trials among 28, 896 women. N. Engl. J. Med., 319, 1681
3. FEINBERG, A.P. & VOGELSTEIN, B. (1983). A technique for radiolabelling DNA restriction endonuclease fragments to a high specific activity. Analyt. Biochem., 132, 6
4. GIGUERE, V., YANG, N., SEGUI, P. & EVANS, R. (1988). Identification of a new class of steroid hormone receptors. Nature, 331, 91
5. GLEIBER, W.E. & SCHIFFMAN, E. (1984). Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines. Cancer Res., 44, 3398
6. GLICK, A.B., FLANDERS, K.C., DANIELPOUR, D., YUSPA, S.H. & SPORN, M.B. (1989). Retinoic acid induces transforming growth factor beta 2 in cultured keratinocytes and mouse epidermis. Cell Regulation, in press
7. GREEN, B. & LEAKE, R.E. (1987). Steroid Hormones - A Practical Approach. IRL Press: Oxford
8. HAGGIE, J.A., SELLWOOD, R.A., HOWELL, A., BIRCH, J.M. & SCHOR, S.L. (1987). Fibroblasts from relatives of patients with hereditary breast cancer show foetal-like behavior in vitro. Lancet, i, 1455
9. HORGAN, K., JONES, D.L. & MANSEL, R.E. (1987). Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br. J. Surgery, 74, 227
10. IQBAL, M.J., CORBISHLEY, T.P., WILKINSON, M L. & WILLIAMS, R. (1985). A microassay for the determination of the binding parameters of oestrogen and androgen receptors employing affinity immobilisation on Cibacron Blue F3GA-Sepharose 6B. Analyt. Biochem., 144, 79
11. JAKOWLEW, S B., DILLARD, P.B., SPORN, M.B. & ROBERTS, A.B. (1988). Complementary deoxyribonucleic acid cloning of a noveltransforming growth factor beta messenger ribonucleic acid from chick embryo chondroytes. Mol. Endocrinol. 2, 1186
12. JORDAN, V.C., ROWSBY, L., DIX, C.J. & PRESTWICH, G. (1977). Dose-related effects of non-steroidal antioestrogens and oest- rogens on the measurement of cytoplasmic oestrgen receptors in the rat and mouse uterus. J. Endocrinol., 75, 305
13. KNABBE, C., LIPPMAN, M., WAKEFIELD, L.M., DERYNK, R. & DICKSON, R.B. (1987). Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417
14. KONDAIAH, P., VAN OBBERGHEN-SCHILLING, E. LUDWIG, R.L., DHAR, R., SPORN, M.B. & ROBERTS, A.B. (1981). cDNA cloning of porcine transforming growth factor beta 1 mRNAs. Evidence for alternate splicing and polyadenylation. J. Biol. Chem., 263, 18313
15. KORENMAN, S.G. & DUKES, B.A. (1970). Specific estrogen binding by the cytoplasm of human breast carcinoma. Endocrinology, 87, 1119
16. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 277, 680
17. LAWRENCE, D.A., PIRCHER, R., KRYCEVE-MARTINERIE, C. & JUL-LIEN, P. (1984). Normal embryo fibroblasts release transforming growth factors in a latent form. J. Cell Physiol., 121, 184
18. MANIATIS, T., FRISCH, E.F. & SAMBROOK, J. (1983). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: New York
19. MEDICAL RESEARCH COUNCIL SCOTTISH TRIALS OFFICE (1988). Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet, ii, 171
20. MURPHY, L.C. & DOTZLAW, M. (1989). Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol. Endocrinol., 3, 687
21. NOLVADEX, ADJUVANT TRIAL ORGANISATION. (1987). Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Br. J. Cancer, 57, 608
22. PIRCHER, R., LAWRENCE, D A. & JULLIEN, P. (1984). Latent betatransforming growth factor in non-transformed and Kirsten virus-transformed normal rat kidney cells, clone 49F. Cancer Res., 44, 5538
23. SKIDMORE, J.R., WALPOLE, A.L. & WOODBURN, J. (1972). Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from the uterus and anterior pituitary. J. Endocrinol., 52, 289
24. SUTHERLAND, R.L. (1981). Estrogen antagonists in the chick oviduct: antagonist activity of eight synthetic triphenylethylene derivatives and their interactions with cytoplasmic and nuclear estrogen receptors. Endocrinology, 109, 2061
25. TEN DUKE, P., HANSEN, P., I WATA, K.K., PIELER, C. & FOULKES, J.G. (1988). Identification of another member of the transforming growth factor type beta family. Proc. Natl Acad. Sci. USA, 85, 4715
26. WAKEFIELD, L.M., SMITH, D M., MATSUI, T., HARRIS, C. & SPORN, M.B. (1987). Distribution and modulation of the cellular receptor for transforming growth factor beta. J. Cell Biol., 105, 965
27. WAKELING, A.E. & BOWLER, J. (1987). Steroidal pure antioestrogens. J. Endocrinol., 112, R7
28. WATTS, C.K.W., MURPHY, L.C. & SUTHERLAND, R.L. (1984). Microsomal binding sites for non-steroidal antioestrogens in MCF-7 human mammary carcinoma cells. E>emonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. J. Biol. Chem., 259, 4